Targeted multidrug delivery system to overcome chemoresistance in breast cancer

Chemotherapy has been widely used in breast cancer patients to reduce tumor size. However, most anticancer agents cannot differentiate between cancerous and normal cells, resulting in severe systemic toxicity. In addition, acquired drug resistance during the chemotherapy treatment further decreases...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yuan, Soroush, Fariborz, Tong, Zhaohui, Kiani, Mohammad F, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268372/
https://www.ncbi.nlm.nih.gov/pubmed/28176940
http://dx.doi.org/10.2147/IJN.S124770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268372/
https://www.ncbi.nlm.nih.gov/pubmed/28176940
http://dx.doi.org/10.2147/IJN.S124770

Ejemplares similares